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Serum-free media supplements carry miRNAs that co-purify with extracellular
vesicles
Martin Aubera, Dominik Fröhlicha*, Oliver Drechselb, Emil Karaulanovb and Eva-Maria Krämer-Albers a
aInstitute of Developmental Biology and Neurobiology, Biology of Extracellular Vesicles, University of Mainz, Mainz, Germany;
bBioinformatics Core Facility, Institute of Molecular Biology, Mainz, Germany
ABSTRACT
Recent studies on extracellular RNA raised awareness that extracellular vesicles (EVs) isolated from
cultured cells may co-purify RNAs derived from media supplements such as fetal bovine serum
(FBS) confounding EV-associated RNA. Defined culture media supplemented with a range of
nutrient components provide an alternative to FBS addition and allow EV-collection under full
medium conditions avoiding starvation and cell stress during the collection period. However, the
potential contribution of serum-free media supplements to EV-RNA contamination has remained
elusive and has never been assessed. Here, we report that RNA isolated from EVs harvested from
cells under serum-replacement conditions includes miRNA contaminants carried into the sample
by defined media components. Subjecting unconditioned, EV-free medium to differential cen-
trifugation followed by reverse transcription quantitative PCR (RT-qPCR) on RNA isolated from the
pellet resulted in detection of miRNAs that had been classified as EV-enriched by RNA-seq or RT-
qPCR of an isolated EV-fraction. Ribonuclease (RNase-A) and detergent treatment removed most
but not all of the contaminating miRNAs. Further analysis of the defined media constituents
identified Catalase as a main source of miRNAs co-isolating together with EVs. Hence, miRNA
contaminants can be carried into EV-samples even under serum-free harvesting conditions using
culture media that are expected to be chemically defined. Formulation of miRNA-free media
supplements may provide a solution to collect EVs clean from confounding miRNAs, which
however still remains a challenging task. Differential analysis of EVs collected under full medium
and supplement-deprived conditions appears to provide a strategy to discriminate confounding
and EV-associated RNA. In conclusion, we recommend careful re-evaluation and validation of EV
small RNA-seq and RT-qPCR datasets by determining potential medium background.
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Introduction
Extracellular vesicle (EV) research has been strongly
promoted by the discovery of different classes of RNAs,
mainly mRNAs and miRNAs, which in association
with EVs are delivered to target cells and are consid-
ered to modulate various target cell functions [1–3].
Since these pioneering findings, numerous studies
reported RNA-seq and miRNA-profiling on EVs that
were isolated from cell culture supernatants. Most cell
types and in particular tumour cells are cultured in the
presence of foetal bovine serum (FBS). However, FBS
contains EVs as well as other macromolecular com-
plexes such as ribonucleoprotein and lipoprotein par-
ticles, which carry RNAs and co-isolate in common
EV-isolation protocols, introducing potential artefacts
leading to misinterpretation of RNA topology during
the analysis of extracellular RNA [4–6]. Furthermore,
miRNAs share high sequence homology between spe-
cies resulting in erroneous species annotation. In fact,
a considerable number of FBS-associated miRNAs are
indistinguishable from their human and rodent ortho-
logs [7]. Despite the use of EV-depleted FBS during the
EV-collection period, adverse effects on cell growth
were observed and a substantial proportion of EVs
and RNA still persist after depletion [7–10].
Therefore, it was suggested to carefully consider poten-
tial mis-annotation of FBS-derived RNAs, avoiding
them being wrongly perceived as genuine EV-RNAs.
A promising strategy to circumvent FBS-RNA con-
taminations in EV-isolates could be the substitution of
FBS by chemically defined media supplements, allow-
ing controlled and optimized growth conditions also
during EV-collection periods. Several primary cultured
cell types or stem cells are commonly cultured in the
CONTACT Eva-Maria Krämer-Albers alberse@uni-mainz.de Institute of Developmental Biology and Neurobiology, Biology of Extracellular Vesicles,
University of Mainz, Mainz, Germany
*Present address: Translational Neuroscience Facility and Department of Physiology, School of Medical Sciences, UNSW Sydney, Australia
Supplemental data for this article can be accessed here.
JOURNAL OF EXTRACELLULAR VESICLES
2019, VOL. 8, 1656042
https://doi.org/10.1080/20013078.2019.1656042
© 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of The International Society for Extracellular Vesicles.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which
permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
presence of commercially available media supplements.
For example, the supplements B27 or NS21 are often
used for cells of neural origin [11,12]. Here, we illus-
trate that small RNA-seq data obtained for EVs col-
lected under serum-free, defined media conditions are
still confounded by contaminating miRNAs that are
carried in by media supplements. By careful analysis
of individual media components, we identified the
potential source of RNA contamination.
Material and methods
Cell culture
Primary oligodendrocytes were prepared from
embryonic day (E) 14 or postnatal day (P) 7–9 mice of
the C57Bl/6-N strain as described before [13,14]. Primary
oligodendrocytes derived from E 14 mice were cultured
in Sato 1% horse serum (Thermo Fisher Scientific),
washed in PBS and switched to serum-free Sato supple-
mented with B27 [11] (purchased from Gibco) before the
harvesting period of EVs. Primary oligodendrocytes
derived from P 7–9 mice were cultured in basal medium
(MACS Neuro Medium, Miltenyi Biotec) supplemented
with NS21 [12] (NB21 supplement, Miltenyi Biotec),
1 mM L-glutamine and 10 ml/l 100x Penicillin-
Streptomycin (Thermo Fisher Scientific).
Sm-NS16, sm-NS19 and sm-NS21 supplements
In order to compare self-made supplements to commer-
cially available NS21 (Miltenyi Biotec), neural supple-
ments were prepared by mixing individual components
as described [12]. Self-made (sm)-NS21 reflects the full
supplement, while sm-NS19 is lacking SOD and Catalase,
and sm-NS16 is lacking all protein components (compo-
nents listed in Supplementary Table 1).
Isolation of EVs
EVs were collected from primary cultured oligodendro-
cytes in serum-free media either supplemented with B27,
NS21, or without supplement over a period of 24–48 h and
isolated by differential centrifugation as described with
minormodifications [15,16]. Briefly, supernatants (derived
from 5–15 × 106 cells in a volume of 12–30 ml) were
subjected to centrifugation at 130 x g for 10 min (4°C),
followed by 10,000 x g for 30 min (4°C) in a fixed angle
rotor (220.78, Hermle, Wehingen, Germany) and ultra-
centrifugation at 29,000 rpm for 2 h at 4°C using
a Beckman SW40 Ti rotor (RCF (avg) 106,154, RCF
(max) 149,576, k-factor 260) and 14 ml polyallomer tubes
(Beckman Coulter). Unconditioned media (25 ml input)
was handled equally. Pellets were resuspended in 700 µl
QIAzol (Quiagen) and stored at −80°C before RNA-
isolation.
For depletion of NS21, 0.2 ml of NS21 supplement was
subjected to ultracentrifugation for 2 h at 47,000 rpmat 4°C
(Beckman TLA-55 rotor, RCF (avg) 98,963, RCF (max)
130,000, k-factor 90.4). Pellet and supernatant were sub-
jected to RNA-isolation.
RNA isolation
EVs (obtained from culture-conditioned supernatants) as
well as ultracentrifugation pellets derived from uncondi-
tionedmedia were resuspended in 700 µl QIAzol (Qiagen).
Total cells, fromwhichEVswere harvested,werewashed in
ice-cold PBS before scraping in the recommended volume
of QIAzol. RNA was isolated using the miRNeasy micro
Kit (Qiagen) according to the manufacturer’s instructions,
including on-column DNase digest and <200 nt cut-off. In
case of unconditioned medium (25 ml supplemented with
0.5 ml of NS21, sm-NS19, or sm-NS21), total RNA was
isolated and DNAse digestion was omitted (as RT-qPCR is
designed to only detect mature miRNAs).
For direct RNA extraction from media supplements,
sm-NS16, NS21 or B27 (0.5 ml supplement, equivalent
to 25 ml supplemented culture medium) were mixed
with QIAzol Lysis Reagent (Qiagen) according to the
manufacturer’s instructions. The following media com-
ponents were individually analysed and subjected to
direct RNA isolation (input normalized to their quan-
titative representation in 25 ml supplemented culture
medium): BSA, superoxide dismutase (SOD), insulin,
holo-Transferrin, and catalases of different origin (see
details in Supplementary Table 2).
Small RNA-seq profiling
Oligodendrocyte-derived EVs, which were characterized
previously [13,15,16], were subjected to quality control by
NTA and Western-blotting. Total RNA of three indepen-
dent biological replicates (n = 3) was isolated from 100.000
x g EV-pellets as well as from corresponding cells as
described above (without 200 nt cut-off). RNA was size-
selected between 15 and 200 nt on 10% TBE-urea gel. Gel-
purified RNAwas eluted overnight in 0,3MNaCl and then
precipitated with 100% isopropanol and Glycoblue for 1
h at −20°C. The pellet was washed once with 75% ethanol
and dissolved in nuclease-free water. The purified fraction
was confirmed by Bioanalyzer Small RNA chip (Agilent).
Library preparation was based on the NEBNext Multiplex
Small RNA Library Prep Set for Illumina (New England
BioLabs) with slight modification. In brief, RNA was first
ligated to the 3ʹ adapter and then to the 5ʹ adapter, both of
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which contained four random bases and were chemically
synthesized by Bio Scientific. Adapter-ligated RNA was
reverse-transcribed and PCR-amplified for 14 cycles
using index primers. The PCR-amplified cDNA construct
was purified using AMPure XP beads (Beckman Coulter).
The purified PCR reaction was checked on the Bioanalyzer
usingHigh SensitivityDNAchip (Agilent). Size selection of
the RNA library was performed on LabChip XT instru-
ment (Perkin Elmer) using DNA 300 assay kit in the range
140–300 bp, the libraries were pooled in equal molar ratio
and sequenced on Illumina HiSeq 2500 for 51 cycles plus 7
cycles index read. Sample demultiplexing and FastQ file
generation was performed using bcl2fastq v.1.8.4
(Illumina). For miRNA-tailored analysis, the raw sequence
reads were cleaned from adapter sequences and size-
selected in the range 19–25 nucleotides (plus 8 random
bases from the adapters) using Cutadapt v.1.7.1 (http://
cutadapt.readthedocs.org). Reads containing low-quality
bases (Phred score below 20) were filtered with the FastX
toolkit (http://hannonlab.cshl.edu/fastx_toolkit) and dedu-
plicated based on full sequence identity (library insert plus
8 random bases from the library adapters) using shell
commands. Quality control of the raw and processed data
was performed with FastQC (http://www.bioinformatics.
babraham.ac.uk/projects/fastqc). Mapping to the mouse
reference genome NCBIM37 (mm9) with concomitant
trimming of the random adapter bases was performed
using Bowtie v.0.12.8 (http://bowtie-bio.sourceforge.net)
with parameters "-v 3-M 1 -y –sam –best –strata –nomaq-
round –trim5 4 –trim3 4". Mature miRNA annotation
from miRbase (http://www.mirbase.org/) was used to esti-
mate the number of reads per miRNA using Subread
featureCounts v.1.4.6-p4 (http://subread.sourceforge.net/
). Differential expression analysis of EVs vs. Cells was
performed using LIMMA v. 3.24.0 (https://bioconductor.
org/packages/release/bioc/html/limma.html) as recom-
mended for RNA-seq data and Volcano plots were pre-
pared using ggplot2 (https://ggplot2.tidyverse.org). Similar
results were obtained using miRNA gene annotation from
UCSC (http://genome.ucsc.edu/cgi-bin/hgTables) andper-
forming differential expression analysis with edgeR
(https://bioconductor.org/packages/release/bioc/html/
edgeR.html). The NGS data have been deposited in the
NCBI’s Gene ExpressionOmnibus (GEO) under accession
number GSE134096 (https://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE134096).
cDNA synthesis and RT-qPCR
As input for reverse transcription of cDNA, 5 ng of cellular
RNA and corresponding EV-RNA was used (determined
byNanodropND3300using theRiboGreenAssay forRNA
quantitation (Thermo Fisher Scientific)). In case of EVs
harvested in presence or absence ofNS21, equal input of 1.7
ng EV-RNA was used (determined by Bioanalyzer, RNA
6000PicoChip (Agilent)). AsRNAwas below the detection
limit in samples derived from media and media supple-
ments, the maximal input volume of 3.7 µl of RNA was
included in the cDNA synthesis reaction of these samples.
A spike-in of cel-miR-39-3p (UCACCGGGUGUAAAU
CAGCUUG, 0.994 amol) was added to each RNA-sample
as a control later used for normalization and inter-sample
calibration of qPCR results. cDNA synthesis was carried
out using the TaqMan Advanced miRNA cDNA Synthesis
Kit (Thermo Fisher Scientific). For RT-qPCR, TaqMan
Fast Advanced Master Mix and TaqMan Advanced
miRNA Assays detecting miR-122-5p, miR-451a, miR-
30d-5p, let-7g or cel-miR-39-3p (Thermo Fisher
Scientific) were used. RT-qPCR was performed with the
StepOne Real-Time PCR System (Applied Biosystems).
Inter-sample calibration of RT-qPCR using spike-in
Spike-in (cel-miR-39-3p)Cq-valueswere determined auto-
matically and individually for all samples via StepOne
Software 2.2.2 (Applied Biosystems). Since spike-in quan-
tity is constant in all samples, an average spike-in Cq-value
was calculated (23.628 ± 0.168, average ± SEM Cq over 46
reactions). To correct for technical variations between
samples, the determined spike-in Cq mean of 23,628 was
used to set the spike-in threshold, which was then applied
to adjust the threshold for the targetmiRNAs of the sample
accordingly (example given in Supplementary Fig. 1). Cq-
cut-off was set to 35.
RNase-A and TritonX-100-treatment
One hundred-microlitre NS21 was treated with 20 μg/
ml RNase A (Invitrogen) or with 1% (V/V) TritonX-
100 (Sigma-Aldrich) followed by 20 μg/ml RNase A for
30 min at 37°C under gentle agitation. RNase digestion
was stopped by addition of 1.25 μl/ml RNasin Plus
RNase Inhibitor (Promega) and RNA-isolation was
performed as described above.
Western blotting and antibodies
Unconditionedmedia supplementedwithNS21, sm-NS21,
or sm-NS19 (25 ml) were subjected to the EV isolation
protocol including final ultracentrifugation as described
above. Pellets were resuspended in SDS-PAGE sample
buffer and stored at −20°C. Before loading on a 12% SDS-
PAGE (Bio-Rad Mini PROTEAN electrophoresis system),
the samples were boiled 10 min at 70°C. Proteins were
transferred onto a PVDF membrane for 3 h and 300 mA
(Bio-Rad Mini Trans-Blot Electrophoretic Transfer Cell
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system). The membrane was blocked with 4% milk pow-
der/0.1% Tween (Roth) in PBS. Proteins were detected by
sequential incubation of the membrane with primary anti-
bodies – rabbit-anti-Catalase (sc-271803, Santa Cruz), rab-
bit-anti-SOD (Abcam ab51254) – and horseradish
peroxidise-coupled secondary antibodies anti-rabbit
(Dianova). Signal detection was performed using self-
made enhanced chemiluminescence reagents and exposure
of ECLHyperfilms (GE healthcare), which were developed
with the OptiMax XRay film processor (MS Laborgeräte
Wiesloch).
MTT-assay
As readout of cell viability, metabolic activity of primary
oligodendrocytes cultured in NS21 or sm-NS19 was mea-
sured by MTT-assay. Briefly, 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (Thiazolyl Blue
Tetrazolium Bromide, Sigma) was added to the culture
medium in a final concentration of 0.5 mg/ml and incu-
bated for 1,5 h (37°C, 5%CO2). Subsequently,mediumwas
removed and formed formazan crystals were dissolved in
isopropanol under gentle shaking for 30 min. Absorbance
was measured at 562 nm using a plate reader (Tecan
Infinite 2000).
EV-TRACK
We have submitted all relevant data of our experiments to
the EV-TRACK knowledgebase (EV-TRACK ID:
EV190027) [17].
Results and discussion
Small RNA-seq suggests contamination with
foreign miRNAs
With the goal to identify miRNAs and other small RNAs
involved in EV-mediated oligodendrocyte-neuron com-
munication, we performed deep sequencing (RNA-seq)
of small RNAs derived from EVs isolated from culture
supernatants of primary cultured oligodendrocytes by
differential centrifugation. The efficiency of the isolation
protocol and the resulting EVs were validated and char-
acterized before [13,15,16,18]. To avoid serum-derived
RNA contamination, EVs were harvested under defined
medium conditions using B27 supplement. Bioinformatic
analysis of RNA-seq data from EVs and their correspond-
ing cells of origin revealed several miRNAs enriched in
EVs versus cells or vice versa. The two most significantly
enriched miRNAs in oligodendrocyte-derived EVs were
miR-122-5p and miR-451a (Figure 1(a)), which are
highly expressed in liver and erythrocytes, respectively.
Other miRNAs such as miR-30d-5p and let-7g appeared
equally represented in EVs and cells and were intended to
serve as normalization reference during validation. RT-
qPCR detection of these miRNAs on newly generated
RNA samples (now derived from oligodendrocytes cul-
tured in presence of the advanced NS21 supplement)
verified the anticipated distribution of these miRNAs
between EVs and cells (Figure 1(b)). In the absence of
a validated miRNA that could serve for normalization
between cells and EVs, RT-PCRs were normalized to
RNA-input (small RNA <200 nt). miR-122-5p and miR-
451a were detected with lower RT-qPCR cycle of quanti-
fication (Cq) in EVs versus cells (miR-122-5p: Cq EVs
21.2/cells 29.9; miR-451a: Cq EVs 24.3/cells 26.9) and
thus appeared more abundant in EV-RNA. On the
other hand, Cq-values of miR-30d-5p and let-7g sug-
gested that these two miRNAs are more equal or slightly
stronger represented in cellular as compared to EV-RNA
(miR-30d-5p: Cq EVs 25.0/cells 23.4; let-7g Cq EVs 24.7/
cells 21.9). The strong enrichment of miR-122-5p and
miR-451a in oligodendroglial EVs was startling, as miR-
122-5p appears largely liver-specific and absent from
brain and miR-451a has highest abundance in blood
[19,20]. However, both miRNAs were suspected before
to reflect serum contaminants in other EV samples and it
has been recommended to carefully control their associa-
tion with EVs in individual data sets [6,7].
We further checked the RNA-seq data set for the pre-
sence of miR-1246, which is generated through non-
canonical biogenesis from a small nuclear RNA of the U2
spliceosome complex [21]. However, miR-1246 appears
highly abundant in FBS and is not produced in rodent
cells according to the present literature [22]. Furthermore,
miR-1246 was detected in diverse mouse cell lines that
were cultured in FBS, suggesting uptake of miR-1246 by
these cells during culture [7,22]. Surprisingly, despite the
absence of FBS in our samples, miR-1246 was robustly
detected in all RNA-seq replicates of EVs and less abun-
dantly in cells (Figure 1(c)). As miR-1246 cannot be
derived from mouse oligodendrocytes, its detection is
most likely due to contamination of the EV-samples with
miRNAs originating from bovine- or primate-sourced
components of the media supplement.
Defined media supplements carry exogenous
miRNAs into EV-samples
We further investigated the possibility of contaminating
miRNAs present in the basal medium or the supple-
ments that may be misinterpreted as EV-associated
miRNAs. To this end, we performed differential ultra-
centrifugation (UC) with unconditioned basal medium
lacking or containing NS21 supplement and checked the
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resulting pellets for the presence of miRNAs by RT-
qPCR, indicating their potential co-purification with
EVs. The input medium volume (25 ml) was in the
same range of that used for EV-isolation and miRNA
detection (maximum of 30 ml). UC-pellets of basal
medium lacking supplement did not show miRNA sig-
nals above background. In contrast, UC-pellets of med-
ium containing NS21 supplement revealed clear signals
for all miRNAs examined (Figure 2(a)), which appear
related to NS21-addition. To provide a direct proof, we
subjected undiluted NS21 as well as B27 supplements to
RNA-isolation and RT-qPCR (Figure 2(b)). Supplement
input corresponded to the amount represented in full
medium samples that were subjected to UC pelleting. In
both NS21 as well as B27 supplements, all tested
miRNAs were robustly detected. Together, the results
demonstrate that media supplements contain miRNAs
that can co-purify with EVs and carry exogenous
miRNAs into EV-samples. Thus, the term “defined”
for such supplements appears incorrect (they are rather
“ill-defined”) and should be avoided.
It is important to note that Cq-values achieved for
the miRNAs largely deliver qualitative information.
Although the sample input amount was similar and
a spike-in miRNA (cel-miR-39) was used to correct
for all steps of the RT-qPCR, a stringent normalization
parameter such as an internal miRNA reference is
lacking. Notably, cell-conditioned containing EVs and
non-conditioned media samples were quite distinct
regarding RNA-content (below detection limit in
unconditioned samples) and variations in RNA-
isolation efficiency remained uncorrected. We thus
Figure 1. RNA-seq results and RT-qPCR verification of EV-associated miRNAs.
(a) Volcano plot of relative representation of miRNAs in oligodendrocytes and oligodendrocyte-derived EVs. MiR-122-5p and miR-451a are strongly
enriched in EVs (two top left dots marked), while miR-30d-5p and let-7g are equally represented in cells and EVs (n = 3). Red dotted line:
significance level of 1% FDR (adjusted pValue = 0.01). logFC: log2 Fold Change, AveExpr: Average Expression. (b) RT-qPCR verification of miR-122-
5p, miR-451a, miR-30d-5p and let-7g with independent biological replicates of cells and EVs (n = 3). Dashed line, cut-off Cq 35 defining background
qPCR signal; error bars, SEM. (C) RNA-seq results indicate enrichment of the bovine- and primate-specific miR-1246 in EVs samples versus cells in all
three replicates. RPM: Reads Per Million.
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refrain from a quantitative comparison of the different
sample types. The cel-miR-39 spike-in served for
threshold setting and normalization of similar samples
and replicates (Supplementary Fig. 1). We would like
to emphasize that the qualitative proof of miRNA
contaminations in the medium should be viewed lar-
gely as an alert, which requires follow up of specific
miRNAs in question. However, due to the reasons
outlined above (absence of internal sample normaliza-
tion), quantitative strategies of background subtraction
are considered difficult to achieve.
Supplement-associated miR-122-5p is partly
resistant to RNase treatment
We further explored potential strategies to get rid of the
contaminating miRNAs in supplements that can be
employed for EV-harvesting under full-media conditions.
Resistance of miRNAs to RNase digestion and, further-
more, sensitivity to successive Triton-X100 and RNase
treatment are often used as an argument for EV-
association of miRNAs, as these are enclosed by a lipid
bilayer and only accessible to digestion after detergent
treatment [23]. To test how supplement-associated
miRNAs perform under these conditions, we treated
NS21 supplement with RNase A followed by RNA isola-
tion and RT-qPCR (Figure 2(c)). Although all miRNAs
were affected by RNase-digestion andmiR-451a, miR-30d-
5p and let-7g were below the detection threshold, miR-
122-5p was still detected to a significant extent (Cq-value
26,6 ± 0.34). Consecutive Triton-X100 and RNase
A treatment of NS21 had only slight effects on miR-122-
5p resistance (Cq-value 29.4 ± 1.16) indicating that its
protection is not based on the presence of a lipid layer.
Figure 2. RT-qPCR analysis indicates miRNA contamination of defined media supplements.
(a) RT-qPCR of miRNAs derived from a pellet after differential ultracentrifugation (UC) of unconditioned basal medium (n = 3) or NS21
supplemented medium (n = 4, two different lots included, 2n each). Supplemented medium contains miR-122-5p, miR-451a, miR-30d-5p and
let-7g, while basal medium is free of these miRNAs. Input volume for all samples: 25 ml. (b) RT-qPCR of miRNAs directly isolated from media
supplements NS21 (n = 4, two different lots included, 2n each) and B27 (n = 2). Supplement input volume of 500 µl reflects amount represented in
25 ml used for UC-pelleted samples in (A). (c) RNase A treatment or combined Triton X-100/RNase A treatment of NS21 indicates partial protection
of miR-122-5p to both treatment conditions. (d) RT-qPCR of miRNAs derived from supernatant and pellet fraction after depletion of NS21
supplement by ultracentrifugation. All miRNAs are detected in the pellet and supernatant indicating that depletion does not efficiently remove
miRNAs from the supplement (n = 1). Dashed line, cut-off Cq 35 defining background qPCR signal; error bars, SEM.
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Hence, miR-122-5p is partly resistant to RNase digestion,
but RNase protection is most likely not due to association
with EVs that could be present in the supplement. These
results suggest that some miRNAs are present in macro-
molecular complexes together with proteins, that are not
dissolved by amphipathic detergents, and therefore are
inaccessible to RNase digestion [24]. Most likely, protei-
nase treatment would render miR-122-5p sensitive to
RNAse digestion. Nonetheless, we abstained from per-
forming this experiment as it would destroy the supple-
ment components and not provide a sensible approach to
deplete it from contaminating miRNAs.
To investigate, whether NS21 can be depleted from
miRNA contaminants, we further subjected NS21 to UC
(20h, 100.000 x g) and examined the pellet and supernatant
fractions for the distribution of NS21-associated miRNAs.
All miRNAs were present in the pellet as well as the super-
natant, demonstrating that depletion of miRNAs by UC
was not efficient (Figure 2(d)). Recent studies indicated
that UC-depletion is not sufficient to generate RNA-free
FBS [7,8] and that the quantity and type of depleted RNAs
are affected by variations of the depletion protocol [8].
Therefore, it is not surprising that UC-depletion of supple-
ments is not appropriate to remove RNA-contaminants
and we did not explore this strategy further. However,
RNase treatment of defined media supplements might be
considered as an approach to minimize associated RNA-
contaminants, but similar to UC-depletion for FBS, should
not be expected to eliminate this problem completely.
Catalase is a source of miRNA contamination in
NS21 supplement
Next, we tried to identify the supplement components
responsible for the miRNA-contamination, to explore the
possibility of formulating a culture medium free of con-
taminants. Since the most prominently detected NS21-
contaminants, miR-122-5p and miR-451a, are highly
abundant in liver and blood, we checked the original
NS21 formulation [12] for animal-derived components
that are purified from these tissues. In addition to bovine
serum albumin (BSA), NS21 contains Superoxide dismu-
tase (SOD) and Catalase derived from bovine erythrocytes
and liver, respectively. Of note, both SOD and Catalase (as
well as BSA, not depicted) are clearly detected in the
100.000 x g pellet, whenmedium supplemented with com-
mercially available NS21 is subjected to UC (Figure 3(a)).
Hence, these components will co-isolate with EVs in UC-
pellets and could be responsible for carrying exogenous
miRNAs into EV-samples. With the notion of creating
a miRNA-free supplement, we generated a self-made
defined supplement (sm-NS19) lacking SOD and Catalase
but not BSA, which is an essential component of the
medium (see Supplementary Table 1). Similar to commer-
cialNS21, Catalase and SODwere detected in theUC-pellet
when added to the self-made supplement (sm-NS21). RT-
qPCR analysis of these self-made supplements demon-
strated that sm-NS19 was clean from the miRNAs tested,
while sm-NS21 included miR-122-5p (Figure 3(b)), indi-
cating that either SOD or Catalase are responsible for this
contamination. To examine the influence of contaminant-
free sm-NS19 lacking SOD and Catalase on the growth of
primary oligodendrocytes, we measured the metabolic
activity of cells cultured in sm-NS19 compared to sm-
NS21. The metabolic activity of cells cultured in sm-NS19
was significantly reduced by 13 ± 2%, indicating that
growth conditions are suboptimal (Figure 3(c)). SOD and
Catalase are enzymes neutralizing reactive oxygen species
most likely protecting cultured cells from oxidative
damage.
We further analysed individual NS21-components for
the presence of miRNAs and focussed on protein compo-
nents purified from animal tissues such as BSA, holo-
Transferrin, SOD, and Catalase as well as Insulin, which
is a recombinant product (Supplementary Table 2). All
other non-protein components of the supplement were
mixed and analysed as pool (sm-NS16-pool).
Intriguingly, the sm-NS16-pool, BSA, holo-Transferrin,
SOD, and Insulin were free of all miRNAs tested (not
shown). BSA of different sources was consistently free of
miRNA signals (not shown), which is remarkable as albu-
min is heavily abundant and a known carrier protein in
blood [25]. The only component that reproducibly
revealed miRNA signals of varying degrees was Catalase
(Figure 3(d)). Consistent with the tissue of origin, liver-
derived Catalase contained significant levels of liver miR-
122-5p, while erythrocyte-derived Catalase contained
blood miR-451a. In fact, Catalase can be heavily contami-
nated by several miRNAs including significant levels of
miR-451a and miR-30d, depending on the lot or the sup-
plier (Figure 3(d)). Why Catalase appears to be prone to
miRNA contamination, whether it has a biological mean-
ing or is associated with its biophysical characteristics,
remains elusive. Notably, Catalase derived from the fungus
Aspergillus niger appeared to be free of the tested miRNAs,
although it is possible that other miRNAs not included in
our RT-qPCR panel could be detected.
Differential analysis of EVs collected in
presence or absence of NS21 supplement
Another possibility to avoid supplement-associated impu-
rities is to perform EV collection under supplement-free
conditions. Comparison of EV-RNA collected under con-
ditions with or without supplement may be informative
regarding the discrimination of supplement-derived and
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EV-associated RNAs. Primary cultured oligodendrocytes
that are differentiated to a mature state do well manage
supplement-deprivation without entering apoptosis (not
shown), although it is unknown to what level it affects
the cellular metabolism. The same batch of cells was used
to harvest EVs either in the presence (EVs+NS21) or
absence of NS21 supplement (EVs-NS21) and RT-qPCR
was performed with equal amounts of EV-RNA isolated
from UC-pellets (Figure 3(e)). EVs+NS21 exhibited the
expected miRNA pattern that is also detected in uncondi-
tioned NS21 supplemented media. In EVs-NS21, miR-
122-5p was clearly undetectable and miR-451a was down
to background level, again confirming these two miRNAs
as contaminants of EV-RNA. Intriguingly, miR-30d-5p
and let-7g were detected at similar levels in EVs+NS21
and EVs-NS21. This demonstrates that, despite their pre-
sence in the NS21 supplement, 30d-5p and let-7g may
reflect genuine EV-miRNAs. However, it should be also
noted that supplement-deprivation may influence miRNA
expression or sorting in the cells affecting the miRNA
pattern of the EVs.
Overall, the differential analysis of EVs collected in
presence or absence of supplement delivers two types of
outcomes: First, it allows the identification of miRNAs
that are only medium-derived and can be excluded from
the analysis. Second, it recognizes supplement-associated
Figure 3. Analysis of NS21 supplement components reveals Catalase as the main source of miRNA contamination.
(a) Western blot analysis of pellets after application of differential ultracentrifugation (EV-isolation protocol) to non-conditioned media supple-
mented with commercial NS21, sm-NS19 lacking SOD and Catalase, or sm-NS21 including SOD and Catalase. Both SOD and Catalase (CAT) are
detected in the pellet. (b) RT-qPCR of miRNAs derived from a pellet after differential ultracentrifugation of non-conditioned sm-NS19 lacking SOD
and Catalase and sm-NS21 including SOD and Catalase. Sm-NS21 is positive for miR-122-5p indicating that SOD or Catalase addition is linked to
miRNA contamination (n = 1). (c) MTT-assay to measure metabolic activity of primary oligodendrocytes cultured in sm-NS19 and sm-NS21. Lack of
SOD and Catalase is associated with significantly reduced metabolic activity of the cells (n = 3, SEM, *p = 0.017, two-way ANOVA). (d) RT-qPCR
analysis of miRNAs associated with Catalase. Mammalian Catalase derived from different suppliers and tissue origin is contaminated to different
degrees with miRNAs, while Catalase from Aspergillus niger is miRNA-free (n = 3). (e) Differential RT-qPCR analysis of miRNAs associated with EVs
collected in the presence (EV+NS21) or absence (EV-NS21) of NS21 supplement. miRNA-122-5p and −451a do only appear in EVs+NS21, while miR-
30d-5p and let-7g are also present in EVs-NS21.
8 M. AUBER ET AL.
miRNAs that are also present in EVs and could be lost by
simple exclusion of all miRNAs detected in the medium
control.
Conclusion
In summary, our results raise unexpected and serious con-
cerns about miRNA contaminations associated with so-
called chemically defined supplements, which co-purify
with EVs and confound EV miRNA analysis. Replacing
FBS by addition of formulated supplements to culture
media does not avoid the problem of potential exogenous
miRNA contaminants in EVRNAdata sets.Wewould like
to emphasize that the study largely is of qualitative nature
and, due to the absence of an internal reference miRNA,
has its limitations in providing precise quantitative infor-
mation. In general, the repeated detection of miR-122-5p
and miR-451a in media supplements, as well as FBS, sug-
gests that these miRNAs could serve as indicators, which
may alert EV-researchers to perform a rigorous verification
analysis at least of specific miRNAs that are studied further
as biomarkers or in a functional context. Although the
panel of miRNAs analysed in this study was restricted,
the source of contamination was attributed to only
a single factor within the supplement, the antioxidant
enzyme Catalase. In fact, Catalase (and SOD) co-isolate
with EVs indicating that media-associated proteins can be
misinterpreted as EV-components too. Formulation of
media lacking Catalase or making use of Catalases derived
from recombinant sources or lower eukaryotes, such as that
of the fungus Aspergillus niger, may help avoiding impu-
rities through exogenous miRNAs in media and EV-
samples. However, it will be difficult, if not impossible to
consistently exclude contamination from supplements, as
the quality of the components varies between supplier and
production lots. Depletion of RNAs by UC or RNase-
digestion does not reliably remove contaminating RNAs.
Supplements free of animal-derived components could
provide an alternative solution.
In conclusion, we recommend rigorous validation of
EV-RNA data by including accurate controls of uncondi-
tioned media samples and if applicable, by comparison of
EVs collected under supplement-free conditions. The
background generated by media supplements may be
very different in individual EV-studies and thus needs to
be addressed in quantitative terms in the specific context.
However, quantitative subtraction of RNA-background
miRNA levels based on algorithms will be difficult to
achieve in the absence of a stringent normalization factor
that allows correction between unconditioned (EV-free)
and cell-conditioned (EV-containing) samples, or between
EV-samples collected in presence or absence of supple-
ment. Finally, our findings are relevant beyond the EV-
RNA research field, as miRNAs in the medium may have
biological impact and influence various cellular functions.
Possibly, the development of completely animal-freemedia
supplements generated on the basis of recombinant tech-
nologies may provide an avenue to optimized defined
media supplements free of contaminating miRNAs in the
future.
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